Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 248,997 | 197,668 | 85,551 | 39,084 | 15,689 |
| Cost of Goods | 71,837 | 77,440 | 54,772 | 32,139 | 16,739 |
| Gross Profit | 177,160 | 120,228 | 30,779 | 6,945 | -1,050 |
| Operating Expenses | 168,542 | 125,833 | 84,840 | 56,382 | 38,790 |
| Operating Income | 9,455 | -5,165 | -53,289 | -49,298 | -39,101 |
| Interest Expense | 7,725 | 8,278 | 7,253 | 1,807 | 4,780 |
| Other Income | 390 | -100 | -3,809 | -1,176 | 553 |
| Pre-tax Income | 2,120 | -13,543 | -64,351 | -52,281 | -43,328 |
| Income Tax | 264 | 173 | -442 | N/A | N/A |
| Net Income Continuous | 1,856 | -13,716 | -63,909 | -52,281 | -43,328 |
| Net Income | $1,856 | $-13,716 | $-63,909 | $-52,281 | $-43,328 |
| EPS Basic Total Ops | 0.05 | -0.39 | -1.93 | -1.72 | -2.64 |
| EPS Basic Continuous Ops | 0.05 | -0.39 | -1.93 | -1.72 | -2.64 |
| EPS Diluted Total Ops | 0.04 | -0.39 | -1.93 | -1.72 | -2.64 |
| EPS Diluted Continuous Ops | 0.04 | -0.39 | -1.93 | -1.72 | -2.64 |
| EBITDA(a) | $25,513 | $9,496 | $-43,124 | $-43,058 | $-33,228 |